Sanofi SA Stock Rating Reaffirmed by AlphaValue (SAN)
Shares of Sanofi SA traded up 1.25% during mid-day trading on Thursday, hitting €75.13. Sanofi SA has a one year low of €18.32 and a one year high of €25.88. The stock’s 50-day moving average is currently €25.28. The company has a market cap of €99.239 billion and a P/E ratio of 19.71.
Several other analysts have also recently commented on the stock. Analysts at Sanford C. Bernstein reiterated an “outperform” rating on shares of Sanofi SA in a research note to investors on Tuesday. They now have a $98.70 price target on the stock. Separately, analysts at Oddo & Cie reiterated a “buy” rating on shares of Sanofi SA in a research note to investors on Tuesday, February 19th. They now have a $109.33 price target on the stock. Finally, analysts at Stonecap Securities cut their price target on shares of Sanofi SA from $0.50 to $0.30 in a research note to investors on Friday, February 15th.
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.